| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma. | Blood | 2009 | 2.07 |
| 2 | Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy. | J Clin Oncol | 2001 | 1.55 |
| 3 | AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma. | Blood | 2015 | 1.48 |
| 4 | More on HIV-associated Kaposi's sarcoma. | N Engl J Med | 2008 | 1.38 |
| 5 | Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma. | PLoS One | 2009 | 0.99 |
| 6 | Antitumor activity of oral 9-cis-retinoic acid in HIV-associated Kaposi's sarcoma. | AIDS | 2002 | 0.82 |